Dental anxiety
Conditions
Interventions
Topical anesthesia with 20% benzocaine (20 subjects)
Topical anesthesia with the combination of lidocaine (25 mg/g) and prilocaine (25mg/g) (20 subjects)
Control: Ointment without an active ingredient (placebo) (20 subjects)
The application of topical medications will be followed by anesthetic injection of the major palatal nerve with 2% lidocaine hydrochloride associated with 1: 100,000 norepinephrine (all the subjects).
Drug
Sponsors
Faculdade de Odontologia da Universidade de São Paulo
Faculdade de Odontologia da Universidade de São Paulo
Eligibility
Inclusion criteria
Inclusion criteria: ASA I Need for extraction of bilateral superior third molars.
Exclusion criteria
Exclusion criteria: Patients with systemic comorbidities; Pregnant or breastfeeding women; Patients taking continous use medications; Patients with a history of anemia or methemoglobinemia; Patients with a history of drug allergy to the drugs selected for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the effect of anxiety on pain perception after topical anesthesia immediately after the injection, using quantitative (hemodynamic variations) and qualitative (verbal pain scale) methods. The significance level among groups will be set as 5%. | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate whether topical anesthesia has a physiological or a psychological effect on pain perception in dental anxiety patients, using quantitative (hemodynamic variations) and qualitative (verbal pain scale) methods. The significance level among groups will be set as 5%. | — |
Countries
Brazil
Contacts
Public ContactEmanuela Ferraz
Faculdade de Odontologia da Universidade de São Paulo
Outcome results
None listed